Press Releases October 6, 2026 08:30 AM

Runway Growth Finance Corp. Announces Date for Third Quarter 2026 Financial Results and Conference Call

Runway Growth Finance Corp. schedules release of Q3 2026 financial results and conference call for November 5, 2026

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
RWAY

Runway Growth Finance Corp., a Nasdaq-listed specialty finance company, announced it will release its third quarter 2026 financial results on November 5, 2026, followed by a conference call to discuss results. The company provides flexible capital solutions to late- and growth-stage companies as an alternative to raising equity.

Runway Growth Finance Corp. Announces Date for Third Quarter 2026 Financial Results and Conference Call
RWAY
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Runway Growth Finance will release Q3 2026 financial results after market close on November 5, 2026.
  • A conference call to discuss the results will be held the same day at 2:00 p.m. PT (5:00 p.m. ET).
  • The company focuses on providing alternative capital solutions to late- and growth-stage companies, impacting the specialty finance and growth capital sectors.

MENLO PARK, Calif., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced that it will release its third quarter 2026 financial results after market close on Thursday, November 5, 2026. Runway Growth will discuss its financial results on a conference call that day at 2:00 p.m. PT (5:00 p.m. ET).

To participate in the conference call or webcast, participants should register online at the Runway Growth Investor Relations website. Participants are requested to register a day in advance or at a minimum 15 minutes before the start of the call. The earnings call can also be accessed through the following links:

  • Conference Call
  • Webcast

A replay of the webcast will be available two hours after the call and archived on the same web page for 90 days.

About Runway Growth Finance Corp.

Runway Growth is a specialty finance company focused on providing flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity. Runway Growth is a closed-end investment fund that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended. Runway Growth is externally managed by Runway Growth Capital LLC, an affiliate of BC Partners Advisors L.P., and led by industry veterans David Spreng and Michael Rovner. For more information, please visit www.runwaygrowth.com.

Forward-Looking Statements

Statements included herein may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in forward-looking statements as a result of a number of factors, including those described from time to time in Runway Growth’s filings with the Securities and Exchange Commission. Runway Growth undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.

IR Contacts

Taylor Donahue, Prosek Partners, [email protected]

Carmela Thomson, Chief Financial Officer, [email protected]


Risks

  • Forward-looking statements in the release come with inherent uncertainty and risks that actual results may materially differ.
  • Market conditions and economic factors could affect Runway Growth's performance and financial results.
  • As a business development company regulated under the Investment Company Act of 1940, regulatory changes could impact operations.

More from Press Releases

PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics Oct 6, 2026 Repligen Completes Acquisition of BioLife Solutions Oct 6, 2026 Powerus (Nasdaq: PUSA) Receives $82 Million Order for Counter-Unmanned Aerial Systems Oct 6, 2026 NeOnc’s FDA Catalyst Run Could Give NTHI a Serious Jolt Oct 6, 2026 What Are the Best Holiday Gifts People Will Actually Use? Start With Duluth Trading’s Most-Reviewed Bestsellers Oct 6, 2026